-
BCLI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Brainstorm Cell Therapeutics (BCLI)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 349.00 k | 349.00 k | 349.00 k | 349.00 k | 349.00 k | 349.00 k |
Cash burn (monthly) | 1.10 mm | 72.75 k | 1.02 mm | 1.11 mm | 1.10 mm | 944.17 k |
Cash used (since last report) | 5.57 mm | 368.43 k | 5.15 mm | 5.62 mm | 5.57 mm | 4.78 mm |
Cash remaining | -5.22 mm | -19.43 k | -4.80 mm | -5.27 mm | -5.22 mm | -4.43 mm |
Runway (months of cash) | -4.7 | -0.3 | -4.7 | -4.7 | -4.7 | -4.7 |
13F holders | Current |
---|---|
Total holders | 23 |
Opened positions | 3 |
Closed positions | 32 |
Increased positions | 2 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 764.59 mm |
Total shares | 5.95 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Abbhi Investments | 2.43 mm | $0.00 |
Vanguard | 1.51 mm | $347.45 mm |
Geode Capital Management | 682.82 k | $151.96 mm |
BlackRock | 377.61 k | $86.96 mm |
Liberty Wealth Management | 340.15 k | $78.00 mm |
Daly Joseph Patrick | 165.00 k | $975.00 k |
NTRS Northern Trust | 112.36 k | $25.88 mm |
Raymond James & Associates | 95.15 k | $21.91 mm |
Jmac Enterprises | 65.43 k | $15.07 mm |
WFC Wells Fargo & Company | 52.78 k | $12.15 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jan 25 | Menghisteab Bairu | Common Stock | Grant | Acquire A | No | No | 0 | 24,000 | 0.00 | 24,000 |
1 Jan 25 | Irit Arbel | Common Stock | Grant | Acquire A | No | No | 0 | 30,666 | 0.00 | 41,054 |
1 Jan 25 | Hartoun Hartounian | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 52,000 |
1 Jan 25 | Alla Patlis | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 44,349 |
1 Jan 25 | Frenkel Jacob A | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 43,777 |